2018-02-15 - Jeffery Tessem - How to make more beta cells: exploring molecular pathways that increase functional beta cell mass as a cure for Type 1 and Type 2 diabetes
Submitted by kjones12 on
Both Type 1 (T1D) and Type 2 diabetes (T2D) are caused by a relative insufficiency in functional β-cell mass. Current therapeutic options for diabetes include daily insulin injections to maintain normoglycemia, pharmacological agents to stimulate β-cell function and enhance insulin sensitivity, or islet transplantation. A major obstacle to greater application of islet transplantation therapy is the scarcity of human islets. Thus, new methods for expansion of β-cell mass, applied in vitro to generate the large numbers of human islet cells needed for transplantation, or in situ to induce expansion of the patients remaining β-cells, could have broad therapeutic implications for this disease. To this end, our lab is interested in delineating the molecular pathways that increase β-cell proliferation, enhance glucose stimulated insulin secretion, and protect against β-cell death.
Department of Nutrition, Dietetics and Food Science at BYU
Feb 15, 2018